August 23, 2022 Obtaining and Using TPOXX Tecovirimat for Treatment of Monkeypox An overview of how to obtain and use Tecovirimat (TPOXX) during the 2022 monkeypox public health emergency under Expanded Access I
December 2, 2020 COVID-19: Risk Assessment and Mitigation Strategies for the Collection of PRO Data through Clinical Sites – Lessons Learned This webinar provides an update from sponsors and eCOA providers as they discuss lessons learned from managing clinical trials tha
May 16, 2019 Best Practices for Avoiding Paper Backup When Implementing Electronic Approaches to Patient-Reported Outcome Data Collection in Clinical Trials (May 16, 2019) This webinar provides an overview of the issues related to the use of paper backups in studies for which PRO data is collected ele
In Recognition of 10th Anniversary, Raymond Woosley and Janet Woodcock Address CPAD Consortium’s 2018 Annual Meeting and Regulatory Science Workshop At its 10th Annual Meeting and Regulatory Science Workshop, November 13, 2018, in Bethesda, MD, C-Path’s Critical Path for Alzhe
May 10, 2018 Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium (May 10, 2018) This webinar provides a recommended framework for training end users, including site staff and study participants, on the use of e
HD-RSC Kick-off: Charles Sabine Presentation The kickoff meeting for a new dedicated worldwide consortium focused on Huntington’s disease took place on November 6 and 7 in S
FDA CDER Regulatory Science: The Importance of Partnership and Consortia Dr. Janet Woodcock, Director of the Center for Drug Evaluation and Research within the United States Food and Drug Administration,
June 6, 2017 Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium This webinar provides a recommended framework for the selection and evaluation of wearable devices and their measurements for use
miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry pers
February 28, 2017 Considerations for Requiring Subjects to Respond to PRO Instruments Collected Electronically This webinar provides an overview of specific considerations related to allowing subjects to opt out of responding to individual i